We are live on ! Find out more
Bessemer Group

Bessemer Group Portfolio holdings

AUM $63.6B
1-Year Est. Return 28.76%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$14B
AUM Growth
+$1.63B
Cap. Flow
+$225M
Cap. Flow %
1.61%
Top 10 Hldgs %
16.45%
Holding
1,448
New
199
Increased
366
Reduced
275
Closed
98

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$98.9M
2
GE icon
GE Aerospace
GE
+$95.9M
3
MSFT icon
Microsoft
MSFT
+$92.5M
4
WBA
Walgreens Boots Alliance
WBA
+$67.4M
5
TPR icon
Tapestry
TPR
+$60.5M

Sector Composition

Rank Sector Weight
1 Healthcare 15.01%
2 Technology 14.16%
3 Financials 12.66%
4 Industrials 9.8%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.72T
$454M 3.25%
22,675,772
+206,332
+0.9% +$3.9M
UNP icon
2
Union Pacific
UNP
$181B
$282M 2.02%
3,356,640
+60,850
+2% +$4.82M
IBM icon
3
IBM
IBM
$195B
$208M 1.49%
1,159,712
+147,954
+15% +$25.5M
OXY icon
4
Occidental Petroleum
OXY
$57.3B
$206M 1.48%
2,259,740
+41,437
+2% +$3.78M
KO icon
5
Coca-Cola
KO
$349B
$202M 1.45%
4,895,273
+44,298
+0.9% +$1.75M
IJR icon
6
iShares Core S&P Small-Cap ETF
IJR
$109B
$199M 1.43%
3,654,512
-197,918
-5% -$10.3M
PFE icon
7
Pfizer
PFE
$143B
$192M 1.38%
6,618,788
+187,689
+3% +$5.46M
AAP icon
8
Advance Auto Parts
AAP
$3.22B
$190M 1.36%
1,718,617
+6,070
+0.4% +$602K
EWJ icon
9
iShares MSCI Japan ETF
EWJ
$21.7B
$181M 1.3%
3,729,027
+1,452,429
+64% +$69.2M
ZBH icon
10
Zimmer Biomet
ZBH
$17.3B
$181M 1.3%
1,997,202
+46,431
+2% +$4.02M
WFC icon
11
Wells Fargo
WFC
$261B
$173M 1.24%
3,808,530
+48,545
+1% +$2.1M
COV
12
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$172M 1.24%
2,532,931
+2,820
+0.1% +$183K
BEN icon
13
Franklin Resources
BEN
$16.8B
$171M 1.22%
2,957,628
+975
+0% +$52.6K
VTRS icon
14
Viatris
VTRS
$20.1B
$164M 1.17%
3,765,512
+3,753,155
+30,373% +$154M
VGK icon
15
Vanguard FTSE Europe ETF
VGK
$29.8B
$161M 1.15%
2,735,343
+909,753
+50% +$51.3M
USB icon
16
US Bancorp
USB
$98.7B
$156M 1.12%
3,873,199
+578,693
+18% +$22.2M
AWK icon
17
American Water Works
AWK
$26.2B
$155M 1.11%
3,676,215
+590,277
+19% +$24.7M
DXJ icon
18
WisdomTree Japan Hedged Equity Fund
DXJ
$7.17B
$155M 1.11%
3,055,382
+5,126
+0.2% +$249K
QCOM icon
19
Qualcomm
QCOM
$180B
$154M 1.11%
2,078,712
-47,707
-2% -$3.36M
CL icon
20
Colgate-Palmolive
CL
$72.1B
$153M 1.1%
2,350,318
+18,600
+0.8% +$1.19M
TMO icon
21
Thermo Fisher Scientific
TMO
$213B
$152M 1.09%
1,366,538
+26,635
+2% +$2.65M
FLS icon
22
Flowserve
FLS
$9.16B
$147M 1.05%
1,867,325
+3,930
+0.2% +$272K
CB icon
23
Chubb
CB
$137B
$140M 1%
1,353,010
+29,447
+2% +$2.89M
M icon
24
Macy's
M
$6.14B
$139M 1%
2,608,592
+75,919
+3% +$3.68M
TTE icon
25
TotalEnergies
TTE
$191B
$139M 1%
2,270,087
+65,058
+3% +$3.87M

Similar funds

Bessemer Group's Q4 2013 Portfolio in Review

As of Q4 2013, Bessemer Group held 1,448 positions worth $14B, up 13% from $12.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Bessemer Group's Q4 2013 filing shows 199 new, 366 increased, 275 reduced and 98 closed positions. Its largest new stake was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M. The largest sale was Teva Pharmaceuticals, an estimated $98.9M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • Bessemer Group's largest Q4 2013 buy was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M.
  • Bessemer Group added most to Viatris in Q4 2013, an estimated $154M increase.
  • Bessemer Group's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $98.9M.
  • Bessemer Group fully exited Rayonier in Q4 2013, selling an estimated $33.4M.
  • Bessemer Group's ten largest holdings make up 16% of its $14B portfolio in Q4 2013.
  • Bessemer Group opened 199 new positions and closed 98 in Q4 2013.
  • Bessemer Group's portfolio value rose 13% quarter-over-quarter to $14B.

Based on Bessemer Group's 13F filing for Q4 2013, filed 18 Feb 2014.